Management of Elevated Ferritin and Hemoglobin in a 16-Year-Old
This adolescent requires immediate evaluation for hereditary hemochromatosis with transferrin saturation (TSAT) and HFE genetic testing, followed by therapeutic phlebotomy if iron overload is confirmed. 1, 2
Initial Diagnostic Workup
The combination of elevated ferritin AND elevated hemoglobin in a 16-year-old is concerning for true iron overload rather than inflammatory hyperferritinemia. You must obtain:
- Transferrin saturation (TSAT) - calculated from serum iron and total iron binding capacity
- Complete blood count with reticulocytes - to exclude other red cell disorders
- Liver enzymes (AST/ALT) - to assess hepatic involvement
- HFE genetic testing if TSAT ≥45% 1, 2
The elevated hemoglobin actually supports iron overload, as hemochromatosis patients characteristically have increased mean corpuscular volume and hemoglobin due to enhanced iron availability for erythropoiesis 1. This distinguishes true iron overload from inflammatory hyperferritinemia, where hemoglobin is typically normal or low.
Interpretation Algorithm
If TSAT ≥45% with elevated ferritin:
- Proceed directly to HFE genotyping 1, 2
- Most likely diagnosis is hereditary hemochromatosis (HH)
- In adolescents, consider juvenile hemochromatosis (HJV or HAMP gene mutations) if presentation is severe 1
If C282Y homozygous:
- This confirms HFE-related hemochromatosis
- Assess ferritin level to guide urgency of treatment 2
If ferritin >1000 μg/L with elevated liver enzymes:
- Obtain liver biopsy for hepatic iron concentration and fibrosis staging 1, 2
- Assess for cardiac involvement with ECG and echocardiography 1
If ferritin <1000 μg/L with normal liver enzymes:
- Risk of advanced fibrosis is very low 1
- Can proceed directly to therapeutic phlebotomy without liver biopsy 2
Treatment Approach
Therapeutic Phlebotomy (First-Line Treatment)
Initiate phlebotomy for:
- Males with ferritin ≥300 μg/L 3
- Females with ferritin ≥200 μg/L 3
- Any symptomatic patient regardless of ferritin level 2
Phlebotomy protocol:
- Remove 450-500 mL (1 unit) weekly or twice weekly as tolerated 2
- Check hemoglobin/hematocrit before each session - do not reduce below 80% of baseline 2
- Monitor ferritin every 10-12 phlebotomies (approximately every 3 months) 2
- Target ferritin: 50-100 μg/L (not iron deficiency) 2
- Once target reached, switch to maintenance phlebotomy (frequency varies: monthly to 1-2 units/year depending on reaccumulation rate) 2
Special Considerations for Adolescents
At age 16, this patient is at a critical juncture. Early treatment before age 35 with ferritin in normal range and TSAT <45% has 97% negative predictive value for preventing iron overload complications 2. The key complications that can be prevented with early intervention include:
- Hepatic cirrhosis and hepatocellular carcinoma
- Diabetes mellitus
- Hypogonadotropic hypogonadism (particularly relevant for adolescent development)
- Cardiomyopathy
- Arthropathy 2, 3
If Severe Presentation (Juvenile Hemochromatosis)
If the patient has cardiac symptoms or very high ferritin suggesting juvenile hemochromatosis:
- Cardiac MRI for myocardial iron quantification is mandatory 1
- Consider combination therapy with phlebotomy plus iron chelation (deferasirox 10-15 mg/kg) if cardiac involvement present 1
- Refer to specialized center for management 1
Critical Pitfalls to Avoid
- Do not assume inflammatory cause - The elevated hemoglobin argues against inflammation and supports true iron overload
- Do not delay genetic testing - At age 16, early diagnosis prevents irreversible organ damage
- Do not phlebotomize to iron deficiency - Target ferritin 50-100 μg/L, not <50 μg/L 2
- Do not ignore family screening - All first-degree relatives need HFE testing and iron studies simultaneously 2
Additional Investigations Based on Ferritin Level
If ferritin >1000 μg/L:
- MRI for hepatic iron quantification using R2* sequences 1
- Assess for extrahepatic iron deposition (pancreas, heart) 1
- Screen for advanced fibrosis with non-invasive scores (APRI, FIB-4) though thresholds are lower in hemochromatosis than other liver diseases 1
Regardless of ferritin level:
- Screen for joint involvement (particularly 2nd/3rd metacarpophalangeal joints, ankles) 1
- Assess for endocrine dysfunction (hypogonadism, hypothyroidism) 2
Prognosis with Treatment
If treated before cirrhosis develops, survival is normal 2. Hepatocellular carcinoma accounts for 30% of HH-related deaths and cirrhosis complications another 20%, but HCC is exceptionally rare in non-cirrhotic patients 2. This underscores the critical importance of early diagnosis and treatment in this 16-year-old patient.